{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:11:53Z","timestamp":1760148713257,"version":"build-2065373602"},"reference-count":113,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health Subvention from the IT Simple system of Wroclaw Medical University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The spectrum of immune-mediated neuropathies is broad and the different subtypes are still being researched. With the numerous subtypes of immune-mediated neuropathies, establishing the appropriate diagnosis in normal clinical practice is challenging. The treatment of these disorders is also troublesome. The authors have undertaken a literature review of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), Guillain\u2013Barre syndrome (GBS) and multifocal motor neuropathy (MMN). The molecular, electrophysiological and ultrasound features of these autoimmune polyneuropathies are analyzed, highlighting the differences in diagnosis and ultimately treatment. The immune dysfunction can lead to damage to the peripheral nervous system. In practice, it is suspected that these disorders are caused by autoimmunity to proteins located in the node of Ranvier or myelin components of peripheral nerves, although disease-associated autoantibodies have not been identified for all disorders. The electrophysiological presence of conduction blocks is another important factor characterizing separate subgroups of treatment-naive motor neuropathies, including multifocal CIDP (synonyms: multifocal demyelinating neuropathy with persistent conduction block), which differs from multifocal motor neuropathy with conduction block (MMN) in both responses to treatment modalities and electrophysiological features. Ultrasound is a reliable method for diagnosing immune-mediated neuropathies, particularly when alternative diagnostic examinations yield inconclusive results. In overall terms, the management of these disorders includes immunotherapy such as corticosteroids, intravenous immunoglobulin or plasma exchange. Improvements in clinical criteria and the development of more disease-specific immunotherapies should expand the therapeutic possibilities for these debilitating diseases.<\/jats:p>","DOI":"10.3390\/ijms24119180","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T02:58:48Z","timestamp":1684983528000},"page":"9180","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications"],"prefix":"10.3390","volume":"24","author":[{"given":"Edyta","family":"Dziadkowiak","sequence":"first","affiliation":[{"name":"Department of Neurology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Nowakowska-Kotas","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiktoria","family":"Ra\u0142owska-Gmoch","sequence":"additional","affiliation":[{"name":"Department of Neurology, The St. Jadwiga\u2019s Regional Specialist Neuropsychiatric Centre, Wodoci\u0105gowa 4, 45-221 Opole, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomir","family":"Budrewicz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-1617","authenticated-orcid":false,"given":"Magdalena","family":"Koszewicz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ncl.2020.03.008","article-title":"Immune-Mediated Neuropathies","volume":"38","author":"Gwathmey","year":"2020","journal-title":"Neurol. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.27046","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach","volume":"63","author":"Stino","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40120-020-00184-6","article-title":"The Misdiagnosis of CIDP: A Review","volume":"9","author":"Allen","year":"2020","journal-title":"Neurol. Ther."},{"key":"ref_4","first-page":"452","article-title":"Nerve Imaging, Electrodiagnostics, and Clinical Examination-Three Musketeers to Differentiate Polyneuropathies","volume":"19","author":"Winter","year":"2022","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1007\/s00415-020-09998-8","article-title":"Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"268","author":"Querol","year":"2021","journal-title":"J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"890142","DOI":"10.3389\/fimmu.2022.890142","article-title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Association with Concomitant Diseases: Identification and Management","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European Academy of Neurology\/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force\u2014Second revision","volume":"28","author":"Hadden","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mus.23821","article-title":"Sensory chronic inflammatory demyelinating polyneuropathy: An under-recognized entity?","volume":"48","author":"Ayrignac","year":"2013","journal-title":"Muscle Nerve"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.54.1.26","article-title":"Multifocal inflammatory demyelinating neuropathy: A distinct clinical entity?","volume":"54","author":"Franssen","year":"2000","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/jnnp-2022-329357","article-title":"Comparison of the diagnostic accuracy of the 2021 EAN\/PNS and 2010 EFNS\/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"93","author":"Doneddu","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies (2010). Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Socie. J. Peripher. Nerv. Syst., 15, 185\u2013195.","DOI":"10.1111\/j.1529-8027.2010.00278.x"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/ene.14796","article-title":"Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"28","author":"Broers","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e00932","DOI":"10.1002\/brb3.932","article-title":"Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy","volume":"8","author":"Allen","year":"2018","journal-title":"Brain Behav."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s00415-020-10287-7","article-title":"Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy","volume":"268","author":"Chaudhary","year":"2021","journal-title":"J. Neurol."},{"key":"ref_15","first-page":"874","article-title":"Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies","volume":"19","author":"Briani","year":"2022","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"577725","DOI":"10.1016\/j.jneuroim.2021.577725","article-title":"Anti-MAG neuropathy: From biology to clinical management","volume":"361","author":"Steck","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e10928","DOI":"10.1016\/j.heliyon.2022.e10928","article-title":"Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib","volume":"8","author":"Yasuda","year":"2022","journal-title":"Heliyon"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ajh.25495","article-title":"POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management","volume":"94","author":"Dispenzieri","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00415-018-9110-6","article-title":"POEMS syndrome: Clinical update","volume":"266","author":"Brown","year":"2019","journal-title":"J. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jamaoncol.2021.0586","article-title":"Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review","volume":"7","author":"Khouri","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1212\/WNL.0000000000008697","article-title":"Diagnostic accuracy of MRI and ultrasound in chronic immune-mediated neuropathies","volume":"94","author":"Oudeman","year":"2020","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/jnnp.2004.052282","article-title":"T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"76","author":"Csurhes","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/jnnp-2014-307708","article-title":"Effective treatment with intravenous immunoglobulins reduces autoreactive T-cell response in patients with CIDP","volume":"86","author":"Klehmet","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12974-021-02113-2","article-title":"The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"18","author":"Hagen","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Staudt, M., Diederich, J.M., Meisel, C., Meisel, A., and Klehmet, J. (2017). Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP. BMC Neurol., 17.","DOI":"10.1186\/s12883-017-0860-z"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"116509","DOI":"10.1016\/j.jns.2019.116509","article-title":"Complement deposition and macrophage-induced demyelination in CIDP with anti-LM1 antibodies","volume":"408","author":"Koike","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1093\/brain\/awaa265","article-title":"Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"143","author":"Eftimov","year":"2021","journal-title":"Brain"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4103\/aian.aian_382_22","article-title":"Nodo-paranodopathies: Concepts, Clinical Implications, and Management","volume":"25","author":"Khadilkar","year":"2022","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_30","unstructured":"Nguyen, T.P., and Taylor, R.S. (2023). Guillain Barre Syndrome, StatPearls Publishing."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1212\/CON.0000000000000513","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"23","author":"Donofrio","year":"2017","journal-title":"CONTINUUM Lifelong Learn. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain-Barr\u00e9 syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1128\/IAI.66.8.3649-3655.1998","article-title":"Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barr\u00e9 syndrome exhibit mimicry of GM1 ganglioside","volume":"66","author":"Prendergast","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1084\/jem.178.5.1771","article-title":"A bacterium lipopolysaccharide that elicits Guillain-Barr\u00e9 syndrome has a GM1 ganglioside-like structure","volume":"178","author":"Yuki","year":"1993","journal-title":"J. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jns.2008.05.006","article-title":"Validation of a rabbit model of neuropathy induced by immunization with gangliosides","volume":"272","author":"Moyano","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1523\/JNEUROSCI.4279-04.2005","article-title":"Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy","volume":"25","author":"Goodfellow","year":"2005","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"fcac306","DOI":"10.1093\/braincomms\/fcac306","article-title":"Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model","volume":"4","author":"Campbell","year":"2022","journal-title":"Brain Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/978-3-031-12390-0_16","article-title":"Antibodies to Glycolipids in Guillain-Barr\u00e9 Syndrome, Miller Fisher Syndrome and Related Autoimmune Neurological Diseases","volume":"29","author":"Kusunoki","year":"2023","journal-title":"Adv. Neurobiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/glycob\/cwp027","article-title":"Antiganglioside antibodies and their pathophysiological effects on Guillain-Barr\u00e9 syndrome and related disorders\u2014A review","volume":"19","author":"Kaida","year":"2009","journal-title":"Glycobiology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.2169\/internalmedicine.8416-21","article-title":"Acute Oropharyngeal Palsy Following Bilateral Adie\u2019s Tonic Pupils Associated with Anti-GT1a and GQ1b IgG Antibodies","volume":"61","author":"Murakami","year":"2022","journal-title":"Intern. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.31138\/mjr.31.1.10","article-title":"Autoimmune peripheral neuropathies and contribution of antiganglioside\/sulphatide autoantibody testing","volume":"31","author":"Roggenbuck","year":"2020","journal-title":"Mediterr. J. Rheumatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/joa.13562","article-title":"The role of gangliosides in the organisation of the node of Ranvier examined in glycosyltransferase transgenic mice","volume":"241","author":"McGonigal","year":"2022","journal-title":"J. Anat."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/ene.12658","article-title":"Anti-sulfatide IgM antibodies in peripheral neuropathy: To test or not to test?","volume":"22","author":"Giannotta","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cei.13660","article-title":"Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis","volume":"206","author":"Amor","year":"2021","journal-title":"Clin. Exp. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"613628","DOI":"10.3389\/fnagi.2020.613628","article-title":"The Neuroimmunology of Guillain-Barr\u00e9 Syndrome and the Potential Role of an Aging Immune System","volume":"12","author":"Hagen","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Finsterer, J. (2022). Triggers of Guillain-Barr\u00e9 Syndrome: Campylobacter jejuni Predominates. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214222"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.expneurol.2011.11.039","article-title":"Dysfunction of nodes of Ranvier: A mechanism for anti-ganglioside antibody-mediated neuropathies","volume":"233","author":"Susuki","year":"2012","journal-title":"Exp. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/jnnp-2019-321532","article-title":"Multifocal motor neuropathy: Controversies and priorities","volume":"91","author":"Yeh","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/WCO.0000000000000605","article-title":"Multifocal motor neuropathy","volume":"31","author":"Beadon","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Tozza, S., Spina, E., Iovino, A., Iodice, R., Dubbioso, R., Ruggiero, L., Nolano, M., and Manganelli, F. (2022). Value of Antibody Determinations in Chronic Dysimmune Neuropathies. Brain Sci., 13.","DOI":"10.3390\/brainsci13010037"},{"key":"ref_51","unstructured":"Hameed, S., and Cascella, M. (2023). Multifocal Motor Neuropathy, StatPearls Publishing."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1756285615575269","article-title":"The pathogenesis of multifocal motor neuropathy and an update on current management options","volume":"8","year":"2015","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers","volume":"27","author":"Susuki","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s10072-021-05725-x","article-title":"Multifocal motor neuropathy occurring after acute motor axonal neuropathy: Two stages of the same disease?","volume":"43","author":"Bocci","year":"2022","journal-title":"Neurol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jnnp.2010.205856","article-title":"IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy","volume":"82","author":"Yuki","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.21037\/atm.2018.07.34","article-title":"Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies","volume":"6","author":"Roggenbuck","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bbadis.2014.06.013","article-title":"Pathogenesis of immune-mediated neuropathies","volume":"1852","author":"Dalakas","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/AN20130025","article-title":"Node of Ranvier disruption as a cause of neurological diseases","volume":"5","author":"Susuki","year":"2013","journal-title":"ASN Neuro"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1111\/ene.15428","article-title":"Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies","volume":"29","author":"Kmezic","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1067714","DOI":"10.3389\/fimmu.2023.1067714","article-title":"Systemic inflammatory markers in patients with polyneuropathies","volume":"14","author":"Rausch","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_61","unstructured":"Deisenhammer, F., Teunissen, C.E. (2018). Cerebrospinal Fluid in Neurologic Disorders, Elsevier."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jnnp-2018-318714","article-title":"Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database","volume":"90","author":"Doneddu","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mus.20236","article-title":"Lewis-Sumner syndrome and multifocal motor neuropathy","volume":"31","author":"Verschueren","year":"2005","journal-title":"Muscle Nerve"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s00415-014-7452-2","article-title":"An electrophysiological classification associated with Guillain-Barr\u00e9 syndrome outcomes","volume":"261","author":"Hosokawa","year":"2014","journal-title":"J. Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1016\/j.clinph.2018.09.025","article-title":"The electrodiagnosis of Guillain-Barr\u00e9 syndrome subtypes: Where do we stand?","volume":"129","author":"Uncini","year":"2018","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cnp.2022.09.001","article-title":"Sural-sparing pattern: A study against electrodiagnostic subtypes of Guillain-Barre syndrome","volume":"7","author":"Pasutharnchat","year":"2022","journal-title":"Clin. Neurophysiol. Pract."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Moshe-Lilie, O., Ensrud, E., Ragole, T., Nizar, C., Dimitrova, D., and Karam, C. (2021). CIDP mimics: A case series. BMC Neurol., 21.","DOI":"10.1186\/s12883-021-02118-7"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.1038\/s41598-021-88711-9","article-title":"Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy","volume":"11","author":"Gentile","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.clinph.2013.07.023","article-title":"Heterogeneity of root and nerve ultrasound pattern in CIDP patients","volume":"125","author":"Padua","year":"2014","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000001833","article-title":"CIDP diagnostic pitfalls and perception of treatment benefit","volume":"85","author":"Allen","year":"2015","journal-title":"Neurology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/mus.23503","article-title":"Measurement of cross-sectional area of cervical roots and brachial plexus trunks","volume":"46","author":"Won","year":"2012","journal-title":"Muscle Nerve"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-012-2527-9","article-title":"Ulnar nerve measurements in healthy individuals to obtain reference values","volume":"33","author":"Yalcin","year":"2013","journal-title":"Rheumatol. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/mus.24238","article-title":"Ultrasound differentiation of axonal and demyelinating neuropathies","volume":"50","author":"Grimm","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1007\/s00415-013-7123-8","article-title":"Ultrasound of inherited vs. acquired demyelinating polyneuropathies","volume":"260","author":"Zaidman","year":"2013","journal-title":"J. Neurol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jon.12579","article-title":"Clinical, Sonographic, and Electrophysiologic Longitudinal Features of Chronic Inflammatory Demyelinating Polyneuropathy","volume":"29","author":"Fisse","year":"2019","journal-title":"J. Neuroimaging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/jon.12279","article-title":"Nerve Ultrasound and Electrophysiology for Therapy Monitoring in Chronic Inflammatory Demyelinating Polyneuropathy","volume":"25","author":"Kerasnoudis","year":"2015","journal-title":"J. Neuroimaging"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"9478593","DOI":"10.1155\/2016\/9478593","article-title":"Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data","volume":"2016","author":"Merola","year":"2016","journal-title":"Neurol. Res. Int."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s13311-022-01209-8","article-title":"Nerve Ultrasound Performances in Differentiating POEMS Syndrome from CIDP","volume":"19","author":"Niu","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jns.2014.12.010","article-title":"Bochum ultrasound score allows distinction of chronic inflammatory from multifocal acquired demyelinating polyneuropathies","volume":"348","author":"Kerasnoudis","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1007\/s00415-013-7021-0","article-title":"Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot\u2013Marie\u2013Tooth disease: Distinction from patients with chronic inflammatory demyelinating polyneuropathy","volume":"260","author":"Sugimoto","year":"2013","journal-title":"J. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.0000000000003483","article-title":"Diagnostic value of sonography in treatment-naive chronic inflammatory neuropathies","volume":"88","author":"Goedee","year":"2017","journal-title":"Neurology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/practneurol-2011-000040","article-title":"Cranial nerve, spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy","volume":"12","author":"Shah","year":"2012","journal-title":"Pract. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/ene.13380","article-title":"A comparative study of brachial plexus sonography and magnetic resonance imaging in chronic inflammatory demyelinating neuropathy and multifocal motor neuropathy","volume":"24","author":"Goedee","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e1745","DOI":"10.1212\/WNL.0000000000010369","article-title":"Nerve ultrasound for diagnosing chronic inflammatory neuropathy: A multicenter validation study","volume":"95","author":"Herraets","year":"2020","journal-title":"Neurology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/mus.21431","article-title":"Peripheral nerve size in normals and patients with polyneuropathy: An ultrasound study","volume":"40","author":"Zaidman","year":"2009","journal-title":"Muscle Nerve"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/ene.13344","article-title":"Nerve ultrasound as follow-up tool in treated multifocal motor neuropathy","volume":"24","author":"Rattay","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clinph.2017.10.028","article-title":"Ultrasound and MRI of nerves for monitoring disease activity and treatment effects in chronic dysimmune neuropathies\u2014Current concepts and future directions","volume":"129","author":"Pham","year":"2018","journal-title":"Clin. Neurophysiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.clinph.2013.08.014","article-title":"Nerve ultrasound score in distinguishing chronic from acute inflammatory demyelinating polyneuropathy","volume":"125","author":"Kerasnoudis","year":"2014","journal-title":"Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e17117","DOI":"10.2196\/17117","article-title":"Efficacy and Safety of Rituximab in Refractory CIDP with or without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial","volume":"9","author":"Lewis","year":"2020","journal-title":"JMIR Res. Protoc."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"116497","DOI":"10.1016\/j.jns.2019.116497","article-title":"Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?","volume":"408","author":"Allen","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/mus.27356","article-title":"Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy","volume":"64","author":"Goyal","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"902172","DOI":"10.3389\/fneur.2022.902172","article-title":"Nodopathies in the Early Diagnosis of Axonal Forms of Guillain-Barr\u00e9 Syndrome","volume":"13","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.nrl.2018.06.002","article-title":"Axonal pathology in early stages of Guillain-Barr\u00e9 syndrome","volume":"37","author":"Berciano","year":"2022","journal-title":"Neurologia"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Tonev, D.G., and Momchilova, A.B. (2023). Therapeutic Plasma Exchange in Certain Immune-Mediated Neurological Disorders: Focus on a Novel Nanomembrane-Based Technology. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020328"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00415-016-8204-2","article-title":"Proximal nerve lesions in early Guillain-Barr\u00e9 syndrome: Implications for pathogenesis and disease classification","volume":"264","author":"Berciano","year":"2017","journal-title":"J. Neurol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1093\/brain\/awq260","article-title":"Conduction block in acute motor axonal neuropathy","volume":"133","author":"Kokubun","year":"2010","journal-title":"Brain"},{"key":"ref_97","first-page":"CD001798","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"2","author":"Chevret","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_98","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group (1997). Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Lancet, 349, 225\u2013230.","DOI":"10.1016\/S0140-6736(96)09095-2"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1474-4422(20)30494-4","article-title":"Second intravenous immunoglobulin dose in patients with Guillain-Barr\u00e9 syndrome with poor prognosis (SID-GBS): A double-blind, randomised, placebo-controlled trial","volume":"20","author":"Walgaard","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e27351","DOI":"10.1097\/MD.0000000000027351","article-title":"Efficacy of therapies in the treatment of Guillain-Barre syndrome: A network meta-analysis","volume":"100","author":"Lin","year":"2021","journal-title":"Medicine"},{"key":"ref_102","first-page":"CD001446","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","volume":"10","author":"Hughes","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_103","first-page":"CD001446","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","volume":"10","author":"Hughes","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_104","first-page":"CD004429","article-title":"Immunoglobulin for multifocal motor neuropathy","volume":"1","author":"Keddie","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40265-022-01678-3","article-title":"Efgartigimod: First Approval","volume":"82","author":"Heo","year":"2022","journal-title":"Drugs"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1756286421997381","DOI":"10.1177\/1756286421997381","article-title":"The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors","volume":"14","author":"Dalakas","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(18)30114-5","article-title":"Safety and efficacy of eculizumab in Guillain-Barr\u00e9 syndrome: A multicentre, double-blind, randomised phase 2 trial","volume":"17","author":"Misawa","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/01.WNL.0000092019.53628.88","article-title":"A randomized controlled trial of recombinant interferon-beta 1a in Guillain-Barr\u00e9 syndrome","volume":"61","author":"Pritchard","year":"2003","journal-title":"Neurology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1468-1331.2000.00096.x","article-title":"Randomized controlled trial of brain-derived neurotrophic factor in Guillain-Barr\u00e9 syndrome: A pilot study","volume":"7","author":"Bensa","year":"2000","journal-title":"Eur. J. Neurol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1212\/WNL.57.5.774","article-title":"CSF filtration is an effective treatment of Guillain-Barr\u00e9 syndrome: A randomized clinical trial","volume":"57","author":"Wollinsky","year":"2001","journal-title":"Neurology"},{"key":"ref_111","first-page":"332","article-title":"Effect of Tripterygium polyglycoside on interleukin-6 in patients with Guillain-Barre syndrome","volume":"20","author":"Zhang","year":"2000","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1529-8027.2011.00328.x","article-title":"An open label clinical trial of complement inhibition in multifocal motor neuropathy","volume":"16","author":"Fitzpatrick","year":"2011","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e1107","DOI":"10.1212\/NXI.0000000000001107","article-title":"Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy","volume":"9","author":"Budding","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9180\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:40:52Z","timestamp":1760125252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":113,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["ijms24119180"],"URL":"https:\/\/doi.org\/10.3390\/ijms24119180","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2023,5,24]]}}}